Autenticati per visualizzare i prezzi organizzativi e contrattuali.
Scegli un formato
Cambia visualizzazione
| Taglio della confezione | SKU | Disponibilità | Prezzo |
|---|---|---|---|
| 10 g | Per conoscere la disponibilità, visualizza il carrello | CHF 811.00 |
Informazioni su questo articolo
Formula empirica (notazione di Hill):
C7H12N2O3
Numero CAS:
Peso molecolare:
172.18
MDL number:
UNSPSC Code:
12352202
PubChem Substance ID:
NACRES:
NA.26
EC Number:
211-880-2
Servizio Tecnico
Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.
Permettici di aiutartiNome del prodotto
Gly-Pro,
assay
≥98%
Quality Level
form
solid
technique(s)
ligand binding assay: suitable
color
white
storage temp.
−20°C
SMILES string
NCC(N1[C@H](C(O)=O)CCC1)=O
InChI
1S/C7H12N2O3/c8-4-6(10)9-3-1-2-5(9)7(11)12/h5H,1-4,8H2,(H,11,12)
InChI key
KZNQNBZMBZJQJO-UHFFFAOYSA-N
Application
- Diagnostic efficacy of [(68)Ga]Ga-DOTA-GPFAPI-04 in patients with solid tumors in a head-to-head comparison with [(18)F]F-FDG: results from a prospective clinical study.: This study explores the use of Gly-Pro in peptide imaging agents, specifically [(68)Ga]Ga-DOTA-GPFAPI-04, demonstrating its superior diagnostic performance in detecting solid tumors compared to traditional imaging modalities, offering new avenues for cancer diagnosis and monitoring (Yuan et al., 2024).
- Understanding the Transepithelial Transport and Transbilayer Diffusion of the Antihypertensive Peptide Asn-Cys-Trp: Insights from Caco-2 Cell Monolayers and the DPPC Model Membrane.: This research demonstrates the utility of Gly-Pro in studying the absorption and metabolic stability of antihypertensive peptides, providing key insights into their pharmacokinetic behaviors and enhancing drug delivery strategies (Wu et al., 2024).
1 of 1
Questo articolo | |||
|---|---|---|---|
| form solid | form powder | form powder | form powder |
| assay ≥98% | assay ≥99.0% (NT) | assay - | assay ≥80% (HPLC) |
| technique(s) ligand binding assay: suitable | technique(s) ligand binding assay: suitable | technique(s) ligand binding assay: suitable | technique(s) ligand binding assay: suitable |
| storage temp. −20°C | storage temp. - | storage temp. −20°C | storage temp. −20°C |
| color white | color white | color white | color white to off-white |
| Quality Level 200 | Quality Level 200 | Quality Level 200 | Quality Level 200 |
signalword
Warning
hcodes
pcodes
Hazard Classifications
Eye Irrit. 2
Classe di stoccaggio
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
Scegli una delle versioni più recenti:
Possiedi già questo prodotto?
I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.
E Berardesca et al.
The British journal of dermatology, 126(2), 193-195 (1992-02-01)
A case is reported of a 15-year-old boy with prolidase deficiency and marked urinary excretion of the iminodipeptide gly-pro. Prolidase activity of erythrocytes against substrate glycyl-proline was deficient, but after blood transfusions this was increased to 15.7% of donor activity
Poonam Kalhotra et al.
Biomolecules, 10(2) (2020-02-23)
Diabetes mellitus is a severe health problem in Mexico, and its prevalence is increasing exponentially every year. Recently, DPP-4 (dipeptidyl peptidase-4) inhibitors have become attractive oral anti-hyperglycemic agents to reduce the pathology of diabetes. Gliptin's family, such as sitagliptin, vildagliptin
Rong Qiu et al.
Scientific reports, 10(1), 8231-8231 (2020-05-20)
In this study, we used a new coating agent, that is, ultra-purified alginate gel (UPAL), for fetal liver tissue transplantation. This study aims to compare the effect of UPAL with the effect of other coating agents on improving the effect
Numero articolo commerciale globale
| SKU | GTIN |
|---|---|
| G3002-10G | 04061838354587 |




